All In Biotech

Free tool

FAERS Monitor: Kyprolis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202714 or its brand name (Kyprolis, Carfilzomib). Reports on generic versions are filed under their own applications.

Reports

28,379

Serious

21,874

77% of reports

Hospitalization

9,498

Death reported

4,434

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • plasma cell myeloma3,057
  • off label use2,413
  • death1,768
  • thrombocytopenia1,551
  • fatigue1,549
  • pneumonia1,398
  • pyrexia1,176
  • diarrhoea1,135
  • neutropenia1,127
  • dyspnoea1,122
  • anaemia1,119
  • nausea1,095
  • acute kidney injury874
  • drug ineffective867
  • asthenia724

Reports by year received

View as table
YearReports
20091
20101
201116
2012140
2013317
2014613
20152,140
20162,450
20173,231
20182,601
20192,025
20202,010
20212,289
20222,518
20232,854
20242,286
20251,940
2026947

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,025,780 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal3,05762.960.8171,955
thrombocytopeniaSignal1,55110.49.913,070
neutropeniaSignal1,1276.25.84,886
anaemiaSignal1,1194.44.12,912
acute kidney injurySignal8744.34.02,173
pneumoniaSignal1,3983.23.02,149
pyrexiaSignal1,1762.52.41,095
off label useSignal2,4132.02.01,340
death1,7681.51.5329
fatigue1,5491.51.4246
dyspnoea1,1221.51.4172
asthenia7241.41.394
diarrhoea1,1351.31.282
nausea1,0951.01.01
drug ineffective8670.50.5498

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.